8W85
HLA-DQ2.5-gamma2 gliadin peptide in complex with DQN0385AE01
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | PHOTON FACTORY BEAMLINE BL-1A |
| Synchrotron site | Photon Factory |
| Beamline | BL-1A |
| Temperature [K] | 95 |
| Detector technology | PIXEL |
| Collection date | 2018-12-05 |
| Detector | DECTRIS EIGER X 4M |
| Wavelength(s) | 1.10000 |
| Spacegroup name | C 2 2 2 |
| Unit cell lengths | 150.525, 243.913, 136.081 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 50.470 - 2.769 |
| R-factor | 0.2554 |
| Rwork | 0.253 |
| R-free | 0.29990 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 7VG1 |
| RMSD bond length | 0.008 |
| RMSD bond angle | 1.050 |
| Data reduction software | XDS (Jan 31, 2020) |
| Data scaling software | Aimless (0.7.7) |
| Phasing software | PHASER |
| Refinement software | BUSTER (2.11.8) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 136.081 | 136.081 | 3.105 |
| High resolution limit [Å] | 2.769 | 8.886 | 2.769 |
| Rmerge | 0.120 | 0.030 | 1.883 |
| Rmeas | 0.124 | 0.032 | 1.956 |
| Rpim | 0.034 | 0.009 | 0.524 |
| Total number of observations | 571351 | 27091 | 28797 |
| Number of reflections | 41787 | 2089 | 2089 |
| <I/σ(I)> | 16.25 | 52.89 | 1.57 |
| Completeness [%] | 94.0 | 99.6 | 64.8 |
| Completeness (spherical) [%] | 65.3 | 99.6 | 11.3 |
| Completeness (ellipsoidal) [%] | 94.0 | 99.6 | 64.8 |
| Redundancy | 13.67 | 12.97 | 13.79 |
| CC(1/2) | 0.999 | 0.999 | 0.684 |
| Anomalous completeness (spherical) | 64.6 | 99.8 | 10.9 |
| Anomalous completeness | 94.0 | 99.8 | 63.6 |
| Anomalous redundancy | 7.1 | 7.3 | 7.2 |
| CC(ano) | -0.036 | -0.030 | -0.027 |
| |DANO|/σ(DANO) | 0.8 | 0.7 | 0.7 |
| Diffraction limits | Principal axes of ellipsoid fitted to diffraction cut-off surface |
| 3.510 Å | 1.000, 1.000, 1.000 |
| 3.193 Å | 0.000, 0.000, 0.000 |
| 2.751 Å | 0.000, 0.000, 0.000 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 294 | 0.1 M Ammonium sulfate, 10.0 %w/v Polyethylene glycol 3,350, and 30 %v/v Ethylene glycol as cryoprotectant |






